Trademark Overview
On Monday, March 12, 2001, a trademark application was filed for EZTRANSGENESCREEN with the United States Patent and Trademark Office. The USPTO has given the EZTRANSGENESCREEN trademark a serial number of 76223125. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 19, 2004. This trademark is owned by Mermaid Pharmaceuticals GmbH. The EZTRANSGENESCREEN trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES,AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR SCIENTIFIC OR RESEARCH USE
PHARMACEUTICAL PREPARATIONS FOR USE IN THE DIAGNOSIS OR TREATMENT OF HUMAN DISEASES AND DISORDERS, NAMELY, CIRCULATORY, RESPIRATORY, ENDOCRINE, NEUROLOGIC,CARDIOVASCULAR, ALIMENTARY, ONCOLOGIC, AUTO-IMMUNE OR IMMUNE-RELATED, PULMONARY, MUSCULOSKELETAL, LYMPHATIC, GASTROINTESTINAL, BONE, SENSORY, VIRAL, URINARY, RENAL, INFECTIOUS, METABOLIC OR CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS; DIAGNOSTIC ASSAYS AND TEST KITS FOR CLINICAL, LABORATORY, MEDICAL AND CHEMICAL USE TO DIAGNOSE, PROGNOSE, PREDICT OR TREAT DISEASES AND FOR PROVIDING GENOMIC AND PROTEOMIC PROFILES USEFUL IN THE SELECTION OF THERAPEUTICS; ASSAYS AND TEST KITS FOR EVALUATING EFFICACY OF TREATMENTS AND TREATMENT PROGRESS; PROGNOSTIC TEST KITS FOR IDENTIFYING HEREDITARY RISK FACTORS; DIAGNOSTIC PREPARATIONS NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAGNOSTIC PREPARATIONS FOR CLINICA...
RESEARCH AND DEVELOPMENT SERVICES RENDERED TO OTHERS FOR DISCOVERING SMALL-MOLECULE DRUGS, ANTIBODIES, ANTISENSE DRUGS, PEPTIDES, PROTEINS AND GENE THERAPY DRUGS; MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING,PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENTS BASED ON GENE AND PROTEIN EXPRESSION AND/OR ACTIVITY,EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS